相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's Disease
Nathan Herrmann et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2019)
Assessment of Reported Comparative Effectiveness and Safety of Atypical Antipsychotics in the Treatment of Behavioral and Psychological Symptoms of Dementia A Network Meta-analysis
Ismaeel Yunusa et al.
JAMA NETWORK OPEN (2019)
Investigating the safety and efficacy of nabilone for the treatment of agitation in patients with moderate-to-severe Alzheimer's disease: Study protocol for a cross-over randomized controlled trial
Myuri T. Ruthirakuhan et al.
CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS (2019)
Systematic review and meta-analysis of cannabinoids in palliative medicine
Martin Muecke et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2018)
Effects of tetrahydrocannabinol on balance and gait in patients with dementia: A randomised controlled crossover trial
Geke A. H. van den Elsen et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease
Georgia Watt et al.
FRONTIERS IN PHARMACOLOGY (2017)
A Systematic Review of the Effectiveness of Medical Cannabis for Psychiatric, Movement and Neurodegenerative Disorders
Keane Lim et al.
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2017)
The prevalence of neuropsychiatric symptoms in Alzheimer's disease: Systematic review and meta-analysis
Qing-Fei Zhao et al.
JOURNAL OF AFFECTIVE DISORDERS (2016)
Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study
Assaf Shelef et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Tetrahydrocannabinol in Behavioral Disturbances in Dementia: A Crossover Randomized Controlled Trial
Geke A. H. van den Elsen et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2015)
Tetrahydrocannabinol for neuropsychiatric symptoms in dementia A randomized controlled trial
Geke A. H. van den Elsen et al.
NEUROLOGY (2015)
Safety, pharmacodynamics, and pharmacokinetics of multiple oral doses of delta-9-tetrahydrocannabinol in older persons with dementia
Amir I. A. Ahmed et al.
PSYCHOPHARMACOLOGY (2015)
Dronabinol for the Treatment of Agitation and Aggressive Behavior in Acutely Hospitalized Severely Demented Patients with Noncognitive Behavioral Symptoms
Matthew R. Woodward et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2014)
Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders Report of the Guideline Development Subcommittee of the American Academy of Neurology
Barbara S. Koppel et al.
NEUROLOGY (2014)
Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic
Ester Aso et al.
FRONTIERS IN PHARMACOLOGY (2014)
CB2 Cannabinoid Receptor Agonist Ameliorates Alzheimer-Like Phenotype in AβPP/PS1 Mice
Ester Aso et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Randomized, Controlled Crossover Trial of Dronabinol, 2.5 mg, for Agitation in 2 Patients With Dementia
Sebastian Walther et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2011)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
Alessandro Liberati et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt et al.
BRITISH MEDICAL JOURNAL (2008)
The cannabinoid receptor agonist nabilone for the treatment of dementia-related agitation
Michael J. Passmore
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2008)
Actigraphy in agitated patients with dementia - Monitoring treatment outcomes
R. Mahlberg et al.
ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE (2007)
Cannabinoid pharmacology: the first 66 years
RG Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia
S Walther et al.
PSYCHOPHARMACOLOGY (2006)
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation
Jared Ehrhart et al.
JOURNAL OF NEUROINFLAMMATION (2005)
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
AC Howlett et al.
PHARMACOLOGICAL REVIEWS (2002)
分享论文
